Cargando…
COVID-19 and Listeria Meningitis Treated by Ampicillin, Sulfamethoxazole/Trimethoprim and Meropenem
BACKGROUND: Secondary bacterial infection was initially rare in SARS-CoV-2 infectious disease (COVID-19) patients, but COVID-19-associated bacterial infectious diseases have recently been increasing. Furthermore, it might be difficult to distinguish COVID-19 from bacterial meningitis by the symptoms...
Autores principales: | Seki, Masafumi, Karaushi, Haruka, Arai, Noriko, Hayashi, Takeshi, Mitsutake, Kotaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328099/ https://www.ncbi.nlm.nih.gov/pubmed/37424669 http://dx.doi.org/10.2147/IDR.S414879 |
Ejemplares similares
-
Trimethoprim-sulfamethoxazole induced aseptic meningitis case report
por: Pata, Giulia, et al.
Publicado: (2023) -
A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen
por: Karaushi, Haruka, et al.
Publicado: (2022) -
Trimethoprim-Sulfamethoxazole-Induced Aseptic Meningitis: A New Approach
por: Elmedani, Sarah, et al.
Publicado: (2021) -
In Vitro Killing of Canine Urinary Tract Infection Pathogens by Ampicillin, Cephalexin, Marbofloxacin, Pradofloxacin, and Trimethoprim/Sulfamethoxazole
por: Blondeau, Joseph M., et al.
Publicado: (2021) -
A Rare Complication of Trimethoprim-Sulfamethoxazole: Drug Induced Aseptic Meningitis
por: Jha, Pinky, et al.
Publicado: (2016)